Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival

Background: A higher rate of cancer in systemic sclerosis (SSc) is recognized but the role of SSc-linked autoantibodies status (positive/negative and autoantibody specificities) in the survival of SSc-patients with cancer remains poorly understood. Methods: We utilized the Clalit-Health-Services med...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Autores principales: Watad, Abdulla, McGonagle, Dennis, Bragazzi, Nicola L., Tiosano, Shmuel, Comaneshter, Doron, Shoenfeld, Yehuda, Cohen, Arnon D., Amital, Howard
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2019
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492983/
https://ncbi.nlm.nih.gov/pubmed/31069155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1588084
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares